Subsidiary News

Gemseki Inc. gave a lecture at a seminar on drug development collaboration between Japan and Taiwan in Taiwan on July 16.

27 July

The Taiwan-Japan Industrial Collaboration Promotion Office (TJPO) held a seminar on drug development collaboration between Japanese and Taiwanese pharmaceutical and biotech companies entitled, "A Seminar for Japan-Taiwan Pharmaceutical Products Technology Development Cooperation" in Taiwan. TJPO invited Hideyuki Hirama, president of Gemseki, to give a lecture on licenses called "Possible Collaboration Between Japan and Taiwan in Licensing Activity Fields". There were about 70 participants on the day and active discussions were held.

 

Gemseki Inc. hopes to support the development of pharmaceutical companies in various countries including Taiwan, and hopes to contribute to humanity and society.

 

 

Gemseki Inc. has registered 3 new drug candidates on Drug Candidate Market.

26 July

Gemseki Inc. has registered 3 new drug candidates on Drug Candidate Market. If you are interested in developing the listed items, have ideas for alternative development methods based on the mechanism of action, or would like further information, please contact Gemseki.

 

Gemseki Inc. operates based on a company mission statement of “We strive to make contributions to humanity and society by supporting the best development of valuable drug candidates.”

 

 

Gemseki Inc. gave a lecture at the Futurist meetup “Funding Procurement and Exit Strategy of Start-ups in the Medical Industry” hosted by Digital Garage, Inc. in Kobe on July 22.

24 July

Digital Garage, Inc. invited Hideyuki Hirama, president of Gemseki, to give a lecture entitled "Current Status and Issues of Venture Support in Life Sciences". He spoke about what he has learned from his experience of establishing and supporting startups.

 

Gemseki Inc. hopes to support start-ups through such activities and to contribute to humanity and society.

 

 

Gemseki Inc. has registered 1 new drug candidate on Drug Candidate Market.

20 July

Gemseki Inc. has registered 1 new drug candidate on Drug Candidate Market. If you are interested in developing the listed items, have ideas for alternative development methods based on the mechanism of action, or would like further information, please contact Gemseki.

 

 

Collaboration with University of Maryland, Baltimore

11 July

University of Maryland, Baltimore and Gemseki Inc. have agreed on licensing activity collaboration.